Forthcoming Issue Vol 19 No. 3 ANTIMICROBIAL PRESCRIBING PRACTICES FOR CHILDREN HOSPITALISED WITH RESPIRATORY TRACT ILLNESSES AT A TERTIARY PUBLIC SECTOR HOSPITAL IN SOUTH AFRICA
Article Sidebar
Main Article Content
Abstract
Background. Antimicrobial prescribing practices for children hospitalised with lower respiratory tract infections are infrequently reported, particularly in developing countries.
Objectives. We evaluated the antimicrobials prescribed to children with severe respiratory illness that were hospitalised at Chris Hani Baragwanath Academic Hospital (CHBAH), Johannesburg, from 22 July until 22 September 2021.
Methods. Children aged 1 month to 14 years that were hospitalised with severe acute respiratory illness were enrolled. We assessed frequency of antibiotic usage, admission diagnoses and 28-day outcomes.
Results. Of 183 children screened, 85 (46.4%) were enrolled. The majority of the enrolled children (75/85, 88.2%) received antibiotic therapy. The commonest diagnoses were bronchiolitis (30/85, 35.3%), lower respiratory tract infection (21/85, 24.7%), and pneumonia (18/85, 21.2%). Twenty-five (83.3%) of the children with bronchiolitis were treated with antibiotic therapy. Of the 122 antibiotics prescribed, 109 (89.3%) were classified in the WHO AWaRe groups of antimicrobials, and 95 (77.9%) were ‘Access’ antibiotics. Co-amoxiclav, amoxicillin and ampicillin were the most commonly prescribed antimicrobials. The median length of hospitalisation in those who survived to discharge was 3 days (range 1 to 57 days). Three children died, two in-hospital and one post-discharge.
Conclusion. Antimicrobials are commonly prescribed to children with severe respiratory illness hospitalised at CHBAH. Children with bronchiolitis were commonly treated with antimicrobials, and should be targeted as a major focus group for optimization of antimicrobial stewardship practice.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
McAllister, D.A., Liu, L., Shi, T., Chu, Y., Reed, C., Burrows, J., Adeloye, D., Rudan, I., Black, R.E., Campbell, H. and Nair, H. 2019. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 7(1), pp.e47–e57.
World Health Organization 2005. Chapter 4: Cough or difficult breathing In: World Health Organization, ed. Pocket Book of Hospital care for children: Guidelines for the management of common illnesses with limited resources. Geneva: World Health Organization, pp.72–78.
World Health Organization 2013. Chapter 4: Cough or difficulty in breathing In: World Health Organization, ed. Pocket Book of Hospital care for children: Guidelines for the management of common childhood illnesses [Online]. Geneva: World Health Organization, pp.75–124. Available from: https://apps.who.int/iris/bitstream/10665/ 81170/1/9789241548373_eng.pdf.
Scott, J.A. and English, M. 2008. What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries? PLoS Med. 5(4), p.e86.
Pneumonia Etiology Research for Child Health (PERCH) Study Group 2019. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet.
Bradley, J.S., Byington, C.L., Shah, S.S., Alverson, B., Carter, E.R., Harrison, C., Kaplan, S.L., Mace, S.E., McCracken, Jr., G. H., Moore, M.R., St Peter, S.D., Stockwell, J.A. and Swanson, J.T. 2011. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 53(7), pp.e25–76.
Harris, M., Clark, J., Coote, N., Fletcher, P., Harnden, A., McKean, M. and Thomson, A. 2011. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 66(Suppl 2), p.ii1.
R Core Team, 2021. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria. url: https://www.R-project.org/
Zar, H.J., Moore, D.P., Andronikou, S., Argent, A.C., Avenant, T., Cohen, C., Green, R.J., Itzikowitz, G., Jeena, P., Masekela, R., Nicol, M.P., Pillay, A., Reubenson, G. and Madhi, S.A. 2020. Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines. Afr J Thorac Crit Care Med. 26(3).
Fondazione Penta Onlus 2019. PediCAP. 2019. Available from: https://projectpedicap.org/
Nyquist, A., Gonzales, R., Steiner, J. and Sande, M. 1998. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 279(11), pp.875–877.
Ababneh, M., Al-Azzam, S., Ababneh, R., Rababa’h, A. and Al Demour, S. 2017. Antibiotic prescribing for acute respiratory infections in children in Jordan. Int Health. 9(2), pp.124–130.
Nguyen, P., Tran, H., Fitzgerald, D., Graham, S. and Marais, B. 2020. Antibiotic use in children hospitalized with pneumonia in Central Vietnam. Arch Dis Child. 105(8), pp.713–719.
Malo, S., Bjerrum, L., Feja, C., Lallana, M., Poncel, A. and Rabanaque, M. 2015. Antibiotic prescribing in acute respiratory tract infections in general practice. An Pediatr (Barc). 82(6), pp.412–416.
Hassan, Z., Mojur, B., M., Chowdhury, F., Kafi, M., Braithwaite, J., Jaffe, A. and Homaira, N. 2021. Antibiotic use for acute respiratory infections among under-5 children in Bangladesh: a population-based survey. BMJ Glob Health. 6(4), p.e004010.
Labi, A., Obeng-Nkrumah, N., Dayie, N., Engir, B., Sampane-Donkor, E., Newman, M. and Opintan, J. 2021. Antimicrobial use in hospitalized patients: a multicentre point prevalence study across seven hospitals in Ghana. JAC-AMR. 3(3), p.dlab087.
Gandra, S., Singh, S., Jinka, D., Kanithi, R., Chikkappa, A., Sharma, A., Dharmapalan, D., Vasudevan, A. K., Tunga, O., Akula, A., Garg, G., Hsia, Y., Murki, S., Alvarez-Uria, G., Sharland, M. and Laxminarayan, R. 2017. Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016. Antibiotics (Basel). 6(3), p.19.
Mugada, V., Mahato, V., Andhavaram, D. and Vajhala, S. 2021. Evaluation of prescribing patterns of antibiotics using selected indicators for antimicrobial use in hospitals and the Access, Watch and Reserve (AWaRe) classification by the World Health Organization. Turk J Pharm Sci. 18(3), pp.282–288.
Johnson, D. 2009. Croup. BMJ Clin Evid., p.0321.
Martinez-Gonzalez, N., Keizer, E., Plate, A., Coenen, S., Valeria, F., Verbakel, J., Rosemann, T., Neuner-Jehle, S. and Senn, O. 2020. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomized controlled trials. Antibiotics (Basel). 9(9), p.610.
Cals, J., Chappin, F., Hopstaken, R., Leeuwen, M., Hood, K., Butler, C. and Dinant, G. C-reactive protein point-of-care testing for lower respiratory infections: a qualitative evaluation of experiences by GPs. 2010. Fam. Prac.27(2), p. 212-218.
Bernstein, D., Coster, D., Berliner, S., Shapira, I., Zeltser, D., Rogowski, O., Adler, A., Halutz, O., Levinson, T., Ritter, O., Shenhar-Tsarfaty, S. and Wasserman, A. 2021. C-reactive protein discriminates between acute viral and bacterial infections in patients who present with relatively low CRP concentrations. BMC Infect Dis. 21, p.2110.
Escafadal, C., Incardona, S., Fernandez-Carballo, B. and Dittrich, S. The good and the bad: using C-reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings. 2020. BMJ Glob Health. 5(5), e002396.
Ciccone, E., Kabugho, L., Baguma, E., Muhindo, R., Juliano, J., Mulogo, E. et al., 2021. Rapid diagnostic tests to guide case management of and improve antibiotic stewardship for paediatric acute respiratory illnesses in resource-constrained settings: a prospective cohort study in southwestern Uganda. Microbiol Spectr. 22;9(3): e0169421.
WHO Organisation 2014. Revised WHO classification and treatment of childhood pneumonia at health facilities: Evidence summaries In: Revised WHO classification and treatment of children at health: Evidence summaries [Online]. Geneva: World Health Organization. Available from: https://www.ncbi.nlm.nih.gov/books/NKB264157/.
Papenburg, J., Fontela, P., Freitas, R., Burstein, B., 2019. Inappropriate antibiotic prescribing for acute bronchiolitis in US emergency departments, 2007-2015. Pediatric Infect. Dis. Soc. 8(6) pp. 567 – 570.
Green, R., Zar, H. Jeena, P., Madhi, S., Lewis, H., 2010. South African guideline for the diagnosis, management and prevention of acute viral bronchiolitis in children. S. Afr. Med. J. 100(5).